EXANE DERIVATIVES - QIAGEN NV ownership

QIAGEN NV's ticker is and the CUSIP is N72482AA5. A total of 21 filers reported holding QIAGEN NV in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of QIAGEN NV
ValueSharesWeighting
Q4 2018$2,634,132,000
+888.0%
11
+1000.0%
0.47%
+846.0%
Q3 2018$266,612,000
+3.0%
10.0%0.05%
+16.3%
Q2 2018$258,903,000
-81.9%
1
-83.3%
0.04%
-85.0%
Q1 2018$1,427,146,000
-12.2%
6
-14.3%
0.29%
-5.9%
Q3 2017$1,625,476,000
-39.9%
7
-36.4%
0.30%
-47.7%
Q2 2017$2,704,016,000110.58%
Other shareholders

There were no reported owners of QIAGEN NV in Q3 2018.

NameSharesValueWeighting ↓
View complete list of QIAGEN NV shareholders